Respire Diagnostics Analysis: $59K Raised
What is Respire Diagnostics?
Breath-based medical device for respiratory disease detection
Location
London, United Kingdom
Employees
1-10
Founded
2020
Product Features & Capabilities
- REDI EBC Condenser
- REDI Sensors
- REDI Accessories
Use Cases
Detect COPD and asthma biomarkers in exhaled breath; Monitor sepsis through hydrogen peroxide and lactate levels; Identify respiratory conditions using nitrites as a proxy; Validate biomarker presence in clinical trials with Royal Brompton and Harefield Hospital; Support early-stage disease screening in healthcare settings
Other Considerations
Spin-out from Imperial College London; Funded by UK Research and Innovation's Innovate UK, Medtech SuperConnector and EIT Health; Completed Tech Transfer at Imperial College London (TRL4); Conducted clinical studies at Royal Brompton and Harefield Hospital (TRL5); Working towards ISO13485 regulatory approval
See something that needs updating? Suggest edits to this profile.